Mauri (@MauriDomenech) header
Mauri (@MauriDomenech) profile picture

Ingenierio en Sistemas, emprendedor de nacimiento, Co Creador de EasyKNX

Valencia, Spain
Joined July 2009
Photo by Mauri (@MauriDomenech)Photo by Mauri (@MauriDomenech)Photo by Mauri (@MauriDomenech)Photo by Mauri (@MauriDomenech)Photo by Mauri (@MauriDomenech)Photo by Mauri (@MauriDomenech)Photo by Mauri (@MauriDomenech)Photo by Mauri (@MauriDomenech)Photo by Mauri (@MauriDomenech)Photo by Mauri (@MauriDomenech)
Over the past week, I’ve been overwhelmed by the love and support of friends, industry colleagues, and people I've never met. Thank you to everyone who has shown kindness to my family and me. It means the world to me. I came to the United States 53 years ago, and becoming an American citizen is one of the greatest gifts and proudest moments of my life. NVIDIA has been my life’s work. Building it into the company it is today alongside my colleagues has been a privilege and an honor. Nowhere but in America could a company like NVIDIA be possible. I love our country, and I love NVIDIA. I did not live up to the standards expected of everyone at NVIDIA, and I have made serious mistakes in my personal life. I created problems for the Board that I deeply regret. I own my mistakes completely, and I am committed to cooperating with the Board’s independent investigation. Since my departure, I’ve seen an outpouring of calls from NVIDIA’s employees, investors, business partners, and customers for me to return as CEO. Many continue to reach out to me directly as the company navigates complex technology, market, competitive, and geopolitical dynamics. NVIDIA is a once-in-a-generation company. If the Board of Directors decides that my return is in the best interest of our shareholders, our employees, the company, and America, I would be honored to answer these calls and return as CEO. Thank you again to everyone who has shared their good wishes. I am profoundly humbled by your support. To my family: I love you, and I will spend the rest of my life being worthy of yours. Jensen
56,860
116,864
23,772
1,106,482
50,344,362
Two very different worlds. One incredible year ahead. F1 & Dakar. 2027. @AstonMartinF1 @astonmartin
There are few challenges in motorsport like Dakar. In 2027, @AMR_Official will take it on for the first time. And taking on the challenge: @AstonMartinF1 driver and two-time Formula 1 World Champion @alo_oficial, nine-time World Rally Champion Sébastien Loeb and reigning FIA World Rally Raid Champion Lucas Moraes. At its heart will be Dreadnought. A machine conceived without limits, now being forged into reality for an entirely new kind of competition for Aston Martin. A remarkable new chapter in the Aston Martin Racing story is about to begin. #AstonMartin #AMR #Dakar
219
1,290
80
11,834
209,312
Adivinad quién ha diseñado este dispositivo (incluida la electrónica interior), al 100% (El trípode es comprado)
1
3
18
1,773
Proud to have someone with this mindset on my medical team. Yannick isn't just an amazing professional, his approach to this disease is also in line with the times we live in today.
“Stage 4 cancer" gets heard as a death sentence, but it isn’t one. It’s a description of location. Staging answers a single question: where is the cancer? Stage 4 means it has spread beyond the organ it started in, and nothing more than that. It doesn’t tell you how aggressive the tumor is, what drives it or how long someone has. We hear it as a verdict because for a long time it mostly was, and that has changed unevenly. Metastatic testicular cancer is cured in around 90% of men, and advanced Hodgkin lymphoma is similar, both were near-uniformly fatal a few decades ago. Colorectal cancer that has spread to the liver or lungs can sometimes be removed surgically, with people disease-free a decade later. Metastatic melanoma used to kill within months and now has patients off treatment years on with clean scans. Ofc, for several cancers, stage 4 remains incurable: Pancreatic cancer in that stage won't be cured for most patients despite recent progress. But incurable and untreatable are different words, and confusing them costs people time they could have had. When you look up survival statistics, you are reading history: a 5 year figure published today describes people diagnosed seven to ten years ago and treated with what existed then. Where treatment has moved fast, that number is systematically pessimistic about the person sitting in front of me, because the patients living the current numbers haven’t been counted yet. So the questions that matter aren’t about the number. What’s the molecular profile of the tumor, is there a targetable driver, is there a trial, can anything be removed or radiated? Stage 4 is where the cancer is. It isn’t how long you have.
1
9
1
163
7,472
Esto es una auténtica locura, y demuestra el verdadero potencial de la IA
So get this...a stranger DM'd me on X and offered to help design my backup cancer drug. For free! His name is Jan Domanski @jandom_random. He runs science at @open_fold, an open-source AI model that predicts how proteins and drugs physically fit together. My cancer is driven by one broken protein called ALK. Lorlatinib (the daily pill I take) jams itself into it and shuts it down. It's working. But resistance isn't an if, it's a when. The tumor mutates the pocket and the drug stops fitting. So Jan started modeling it on his own time, burning his own tokens. He ran AI models against ALK and lorlatinib, mapping where the known escape mutations land. And what did he find? Most of them hit right in the drug's pocket, swapping small pieces for bigger ones that physically block the drug. That's the good kind of bad news. A pocket problem is something you can design around. But the normal route to a new drug is ~2 years and ~$4-5M just to be ready for human testing. Jan's dream is getting a medicine to one patient in ~1 month. I'm not taking a homemade molecule while lorlatinib works. But if it ever fails....shit...I've got a guy! I started posting actively on X just a few weeks ago and it has brought me together with the most amazing, generous people!
1
27
177
4,955
Hoy he charlado con @javilop en persona. Desde que empezamos con todo mi caso no habíamos podido vernos. Lo que te da tomarte un café y charlar en persona, son cosas que la IA no nos va a quitar. Tiempo. El tiempo es muy valioso y Javi ha dedicado parte de su tiempo a escucharme. Agradecida de rodearme personas tan generosas y sobre todo humanas.
4
9
204
9,476
Al salir, me acompañó Pp, Vox y Alvise y grabé este vídeo.
1,309
4,793
199
15,418
1,047,089
Polaris corre en un Mac mini M4 de 16 GB en mi casa. Y se está quedando corto: le quedan 18 GB de disco, va con carga 29 en 10 núcleos y la copia de seguridad vive en un pen al que le quedan 7 GB. Vienen datos a procesar grandes, por ejemplo un exoma de unos 74 GB. ¿Que tal este plan para escalar? 1. NAS Synology DS925+ con discos de 8 TB 2. SAI CyberPower CP1350EPFCLCD (1350 VA / 810 W) 3. Copia fuera de casa: Hetzner cifrado o un segundo NAS en casa de alguien de confianza. 4. Nodo Linux: Ryzen 9 9950X, 64 GB, 10 GbE y hueco para 2 GPU. Le quita al Mini lo pesado (IA local, tests, genómica) 5. GPU solo cuando haga falta un modelo local grande. Descartado: Mac Studio o DGX Spark, porque su memoria no crece. El Mini se queda de coordinador: agentes, rutinas y mensajería. ¿Qué cambiaríais? ¿Os cuadra el orden? Para datos genómicos, ¿Hetzner cifrado o segundo NAS? ¿Me estoy dejando algo? 💜
28
18
164
15,863
I think Weight-Space Programming is very good work. Its authors report that GPT-6 Astra edited 0.016% of Qwen3.5-0.8B’s weights and improved its math up to 6x, with no training. Compared to what? I had Polaris check their logs 👇
6
7
1
36
5,430
Anthropic gave me $30,000 in Claude credits to research my own tumor I wrote what I built since March. I’m looking for someone who can manufacture a personalized vaccine, and a hospital that can give it
2
6
126
7,458
Just in case anyone is interested 👇
5
40
2,861
Mil gracias por todas las menciones, ya les he contactado
Launching RNAFoundry.com – we manufacture personalized cancer vaccines.
1
36
1
296
7,068
Que os parece el Pitwall que me está haciendo Sammy para seguir las sesiones de la F1? Aún tiene algunos problemas de Tracking pero creo que es solucionable fácilmente. Ayer seguí las sesiones de libres bastante bien, la verdad
3
4
18
1,340
El último mando a distancia que voy a tener en mi vida: aluminio 7075 mecanizado en CNC, una XIAO nRF52840 y un panel táctil de Cirque. Tercer proyecto con @JLCPCB_ES , después del dial y el bolígrafo. Gracias por embarcaros conmigo otra vez. Electronica 2026 con JLCPCB (entradas y premios): jlcpcb.com/events/electronic… JLCPCB: jlcpcb.com/es?from=OliverNab…
11
28
515
24,599
Hi @TeamYouTube My channel youtube.com/@miriamgonp was in the YouTube Partner Program. I’m an engineer and I made videos about tech and programming. Then, suddenly, I was diagnosed with metastatic breast cancer and I had to stop. Now I want to come back, but I’ve lost monetization. I know this isn’t the usual case, but I stopped for a very exceptional reason. Can you review my case so I can rejoin the program? Thank you.
11
89
2
355
32,864
RT @miriamgonp: Me alegra mucho, y sobre todo me tranquiliza, que toda la parte legal del proyecto Polaris, y a nivel personal la gestiona…
🔴 URGENTE | Adif ha suspendido en dos ocasiones la licitación del nuevo sistema de señalización ERTMS y las coincidencias temporales asustan. La primera, en marzo de 2020, decidieron priorizar 12,5 millones a Soluciones de Gestión para la compra de mascarillas, epicentro del 'caso Koldo'. La segunda, en marzo de 2021, cuando el Consejo de Ministros autorizó una ayuda de 53 millones para el rescate de Plus Ultra exigido por Zapatero. La corrupción y la inutilidad matan, aquí el mejor ejemplo. gaceta.es/espana/adif-suspen…
105
3,660
92
6,673
120,151
Salgo en el top influs que habló de ESMO que fuerte 👇
Thank you Colleagues for a phenomenal #ESMO26 ESMO in Madrid is a wrap, and we are grateful to everyone who shared, discussed, debated and amplified the science this week. You turned five days in Madrid into a truly global conversation. 🌍 OUR Network's MISSION: Keep our colleagues worldwide Up To date in REAL TIME. 📣 101.7M impressions of potential reach 💬 6.1K posts on X from 988 participants in 34 countries ⚡ 43.1 posts per hour across the meeting days 😊 45% positive sentiment, with only 6% negative Real-time metrics powered by ACUVOX. WWW.ACUVOX.IO 🏆 Top influencers @DrChoueiri, @StephenVLiu, @PTarantinoMD, @dr_yakupergun, @HHorinouchi, @zklaassen_md, @stolaney1, @ArndtVogel, @DrYukselUrun, @DraMartinezLago, @tompowles1, @SuyogCancer, @adamfeuerstein, @ScaltritiLab, @GIMedOnc, @ScottGottliebMD, @barriere_dr, @_ShankarSiva, @miriamgonp, @TiansterZhang, @matteolambe, @NiuSanford, @christine_lovly, @amerseburger, @GlopesMd, @montypal, @Icro_Meattini, @PGrivasMDPhD, @brian_rini, @CathyEngMD, @apolo_andrea, @AndreaNecchi, @DrSGraff, @graokane, @to_be_elizabeth, @ElisaAgostinett, @nataliagandur, @UOzkerim, @DrMirallas, @Lucarecco, @mzugman, @p_ciracimd, @DrVilmaPBarcia, @MarioBalsaMD, @scocmem, @GaiaGriguolo, @JankovicK, @Dr_Oncologista 🌎 Where the conversation came from North America led with 1,940 posts, followed closely by Europe with 1,777. Boston, Madrid and New York were the most active cities. 🔬 Top studies by impact 1️⃣ DeLLphi-305 (SCLC): 4.0M reach, 170 posts 2️⃣ VOLGA (bladder): 3.7M reach, 141 posts 3️⃣ KRASCENDO-1 (NSCLC): 3.5M reach 4️⃣ SAFFRON (NSCLC): 3.3M reach 5️⃣ INTerpath-001 (melanoma): 154 posts Pinging our Collaborators
2
3
1
56
2,821
Polaris lleva trabajando 27 días, más de 650 horas en la misma tarea, ni yo se que va a salir de ahí pero estoy muy emocionada
14
33
698
40,854